<?xml version='1.0' encoding='utf-8'?>
<document id="14709903"><sentence text="Studies on intestinal absorption of sulpiride (3): intestinal absorption of sulpiride in rats."><entity charOffset="36-45" id="DDI-PubMed.14709903.s1.e0" text="sulpiride" /><entity charOffset="76-85" id="DDI-PubMed.14709903.s1.e1" text="sulpiride" /><pair ddi="false" e1="DDI-PubMed.14709903.s1.e0" e2="DDI-PubMed.14709903.s1.e0" /><pair ddi="false" e1="DDI-PubMed.14709903.s1.e0" e2="DDI-PubMed.14709903.s1.e1" /></sentence><sentence text="The aim of this study was to investigate whether the concomitant administration of the substrates or inhibitors of PEPT1, OCTN1, OCTN2, and P-glycoprotein affects the intestinal absorption of sulpiride in rats"><entity charOffset="192-201" id="DDI-PubMed.14709903.s2.e0" text="sulpiride" /></sentence><sentence text=" The absorption of sulpiride from rat intestine was decreased by the substrates or inhibitors of PEPT1, OCTN1, and OCTN2"><entity charOffset="19-28" id="DDI-PubMed.14709903.s3.e0" text="sulpiride" /></sentence><sentence text=" On the other hand, the absorption was increased by the substrates of P-glycoprotein" /><sentence text=" The effects of these concomitantly administered drugs on the pharmacokinetic behavior of sulpiride after oral administration in rats were investigated"><entity charOffset="90-99" id="DDI-PubMed.14709903.s5.e0" text="sulpiride" /></sentence><sentence text=" Peak concentration (C(max)) and area under the plasma concentration-time curve (AUC(0-8 h)) of sulpiride were decreased by the concomitant administration of the substrates or inhibitors of PEPT1, OCTN1, and OCTN2"><entity charOffset="96-105" id="DDI-PubMed.14709903.s6.e0" text="sulpiride" /></sentence><sentence text=" However, the same parameters were significantly increased by the concomitant administration of the substrates of P-glycoprotein" /><sentence text=" The present results suggest the possibility of drug-drug interaction during the absorption process in the small intestine due to the coadministration of sulpiride and these agents"><entity charOffset="154-163" id="DDI-PubMed.14709903.s8.e0" text="sulpiride" /></sentence><sentence text=" These findings provide important information for preventing adverse effects and for ensuring the effectiveness of sulpiride and concomitantly administered drugs"><entity charOffset="115-124" id="DDI-PubMed.14709903.s9.e0" text="sulpiride" /></sentence><sentence text="" /></document>